β-Amyloid precursor protein is detectable on monocytes and is increased in Alzheimer’s disease

[1]  H. Fernández,et al.  The Alzheimer's plaques, tangles and memory deficits may have a common origin. Part IV: can calpain act as alpha-secretase? , 1998, Frontiers in bioscience : a journal and virtual library.

[2]  A. LeBlanc,et al.  Protein Kinase C Activation Increases Release of Secreted Amyloid Precursor Protein without Decreasing Aβ Production in Human Primary Neuron Cultures. , 1998, The Journal of Neuroscience.

[3]  N. Cashman,et al.  Prion protein expression in human leukocyte differentiation. , 1998, Blood.

[4]  G. Binetti,et al.  Specific role for protein kinase Cα in the constitutive and regulated secretion of amyloid precursor protein in human skin fibroblasts , 1998, Neuroscience Letters.

[5]  C. Masters,et al.  Distinct sites of intracellular production for Alzheimer's disease Aβ40/42 amyloid peptides , 1997, Nature Medicine.

[6]  R. Doms,et al.  Alzheimer's Aβ(1–42) is generated in the endoplasmic reticulum/intermediate compartment of NT2N cells , 1997, Nature Medicine.

[7]  Y. Ihara,et al.  Intracellular Generation and Accumulation of Amyloid β-Peptide Terminating at Amino Acid 42* , 1997, The Journal of Biological Chemistry.

[8]  J. Buxbaum,et al.  Increased Secretion of the Amino‐Terminal Fragment of Amyloid Precursor Protein in Brains of Rats with a Constitutive Up‐Regulation of Protein Kinase C , 1997, Journal of neurochemistry.

[9]  S. Gauthier,et al.  Lymphocyte content of amyloid precursor protein is increased in Down's syndrome and aging , 1997, Neurobiology of Aging.

[10]  J. Nalbantoglu,et al.  Alzheimer's beta‐amyloid precursor protein is expressed on the surface of immediately ex vivo brain cells: A flow cytometric study , 1996, Journal of neuroscience research.

[11]  M. Alberoni,et al.  Erythrocytic calpain-calpastatin system in Alzheimer’s disease , 1996, Aging.

[12]  M. Trabucchi,et al.  Defective Protein Kinase C α Leads to Impaired Secretion of Soluble β‐Amyloid Precursor Protein from Alzheimer's Disease Fibroblasts a , 1996 .

[13]  S. Gauthier,et al.  Polymerase chain reaction quantification of lymphoid amyloid precursor protein mRNAs in Alzheimer's disease and Down's syndrome , 1995, Neuroscience Letters.

[14]  H. Sorimachi,et al.  Conventional protein kinase C (PKC)‐α and novel PKCε, but not ‐δ, increase the secretion of an N‐terminal fragment of Alzheimer's disease amyloid precursor protein from PKC cDNA transfected 3Y1 fibroblasts , 1995 .

[15]  E. Ikonen,et al.  Intracellular routing of human amyloid protein precursor: Axonal delivery followed by transport to the dendrites , 1995, Journal of neuroscience research.

[16]  S. Grinstein,et al.  Signaling events in monocytes and macrophages. , 1995, New horizons.

[17]  R. Kalaria,et al.  Tau protein directly interacts with the amyloid β-protein precursor: Implications for Alzheimer's disease , 1995, Nature Medicine.

[18]  C. Masters,et al.  Interaction between the zinc(II) and the heparin binding site of the Alzheimer's disease βA4 amyloid precursor protein (APP) , 1994, FEBS letters.

[19]  A. Prochiantz,et al.  Amyloid precursor protein in cortical neurons: coexistence of two pools differentially distributed in axons and dendrites and association with cytoskeleton , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[20]  N. Reiner,et al.  CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. , 1994, Journal of immunology.

[21]  K. Suzuki,et al.  Processing and secretion of Alzheimer's disease amyloid precursor protein. , 1994, The Tohoku journal of experimental medicine.

[22]  K. Beyreuther,et al.  Amyloid precursor protein secretion and βA4 amyloid generation are not mutually exclusive , 1994, FEBS letters.

[23]  C. Masters,et al.  The βA4 amyloid precursor protein binding to copper , 1994 .

[24]  R. Scott,et al.  Alzheimer's disease and down syndrome: leukocyte membrane fluidity alterations , 1994, Mechanisms of Ageing and Development.

[25]  S. Squazzo,et al.  Evidence that production and release of amyloid beta-protein involves the endocytic pathway. , 1994, The Journal of biological chemistry.

[26]  R. Tanzi,et al.  Modulation of A beta adhesiveness and secretase site cleavage by zinc. , 1994, The Journal of biological chemistry.

[27]  R. Tanzi,et al.  Expression of a ubiquitous, cross-reactive homologue of the mouse beta-amyloid precursor protein (APP). , 1994, The Journal of biological chemistry.

[28]  K. Beyreuther,et al.  Amyloid-like properties of peptides flanking the epitope of amyloid precursor protein-specific monoclonal antibody 22C11. , 1993, The Journal of biological chemistry.

[29]  F. Lund-Johansen,et al.  Activation of human monocytes and granulocytes by monoclonal antibodies to glycosylphosphatidelinositol‐anchored antigens , 1993, European journal of immunology.

[30]  Raymond,et al.  Protease nexin-2/amyloid beta protein precursor. A tight-binding inhibitor of coagulation factor IXa. , 1993, The Journal of clinical investigation.

[31]  J. Trojanowski,et al.  Human neurons derived from a teratocarcinoma cell line express solely the 695-amino acid amyloid precursor protein and produce intracellular beta-amyloid or A4 peptides. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[32]  M. Pericak-Vance,et al.  Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[33]  J. Growdon,et al.  Receptor‐coupled Amyloid Precursor Protein Processing a , 1993, Annals of the New York Academy of Sciences.

[34]  C. Masters,et al.  A novel zinc(II) binding site modulates the function of the beta A4 amyloid protein precursor of Alzheimer's disease. , 1993, The Journal of biological chemistry.

[35]  P. Lansbury,et al.  Seeding “one-dimensional crystallization” of amyloid: A pathogenic mechanism in Alzheimer's disease and scrapie? , 1993, Cell.

[36]  R. Sékaly,et al.  Amyloid precursor protein in peripheral mononuclear cells is up-regulated with cell activation. , 1993, Journal of immunology.

[37]  P. McGuffin,et al.  Amyloid precursor protein mRNA levels in the mononuclear blood cells of Alzheimer's and Down's patients. , 1993, Brain research. Molecular brain research.

[38]  P. Lansbury,et al.  The carboxy terminus of the beta amyloid protein is critical for the seeding of amyloid formation: implications for the pathogenesis of Alzheimer's disease. , 1993, Biochemistry.

[39]  B. Strooper,et al.  Study of the synthesis and secretion of normal and artificial mutants of murine amyloid precursor protein (APP): cleavage of APP occurs in a late compartment of the default secretion pathway , 1993, The Journal of cell biology.

[40]  I. Nishimoto,et al.  Alzheimer amyloid protein precursor complexes with brain GTP-binding protein Go , 1993, Nature.

[41]  M. Pericak-Vance,et al.  Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[42]  S. Sisodia.  Secretion of the β‐Amyloid Precursor Protein a , 1992 .

[43]  A. Schmaier,et al.  Potential Role of Protease Nexin‐2/Amyloid β‐Protein Precursor as a Cerebral Anticoagulant a , 1992 .

[44]  J. Shioi,et al.  Evidence for intracellular cleavage of the Alzheimer's amyloid precursor in PC12 cells , 1992, Journal of neuroscience research.

[45]  D. Selkoe,et al.  Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids , 1992, Nature.

[46]  D. Selkoe,et al.  Targeting of cell-surface β-amyloid precursor protein to lysosomes: alternative processing into amyloid-bearing fragments , 1992, Nature.

[47]  S. Younkin,et al.  Potentially amyloidogenic, carboxyl-terminal derivatives of the amyloid protein precursor. , 1992, Science.

[48]  D. Selkoe,et al.  Processing of the amyloid protein precursor to potentially amyloidogenic derivatives. , 1992, Science.

[49]  L. Refolo,et al.  The Alzheimer amyloid precursor is associated with the detergent- insoluble cytoskeleton , 1991, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[50]  R. Cotter,et al.  Secretion of the β/A4 amyloid precursor protein: Identification of a cleavage site in cultured mammalian cells , 1991 .

[51]  D. Selkoe,et al.  Transforming growth factor-beta bound to soluble derivatives of the beta amyloid precursor protein of Alzheimer's disease. , 1990, Biochemical and biophysical research communications.

[52]  S. Wagner,et al.  Immunopurification and protease inhibitory properties of protease nexin-2/amyloid beta-protein precursor. , 1990, The Journal of biological chemistry.

[53]  T. Oltersdorf,et al.  Cleavage of amyloid beta peptide during constitutive processing of its precursor. , 1990, Science.

[54]  Neil R. Cashman,et al.  Cellular isoform of the scrapie agent protein participates in lymphocyte activation , 1990, Cell.

[55]  R. Neve,et al.  The Alzheimer amyloid precursor protein. Identification of a stable intermediate in the biosynthetic/degradative pathway. , 1990, The Journal of biological chemistry.

[56]  F. Coffman,et al.  Aging and deffective lymphoid cell activation , 1989, Experimental Gerontology.

[57]  G. Cole,et al.  The regulation of amyloid β protein precursor secretion and its modulatory role in cell adhesion , 1989, Neuron.

[58]  D. Selkoe,et al.  Amyloid β-protein deposition in tissues other than brain in Alzheimer's disease , 1989, Nature.

[59]  Andreas Weidemann,et al.  Identification, biogenesis, and localization of precursors of Alzheimer's disease A4 amyloid protein , 1989, Cell.

[60]  G. Eisenbarth,et al.  Trisomy 21 (Down's syndrome): autoimmunity, aging and monoclonal antibody-defined T-cell abnormalities. , 1989, Journal of autoimmunity.

[61]  D. Selkoe,et al.  Beta-amyloid precursor protein of Alzheimer disease occurs as 110- to 135-kilodalton membrane-associated proteins in neural and nonneural tissues. , 1988, Proceedings of the National Academy of Sciences of the United States of America.

[62]  K. Grzeschik,et al.  The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor , 1987, Nature.

[63]  F. R. Brown,et al.  Immunologic dysfunction: simultaneous study of alzheimer's and older down's patients , 1987, Mechanisms of Ageing and Development.

[64]  D. Luchins,et al.  Senile dementia of Alzheimer's type (SDAT) , 1985, Neurology.

[65]  M. Folstein,et al.  Clinical diagnosis of Alzheimer's disease , 1984, Neurology.

[66]  R. Walford.  Immunological Studies of Down's Syndrome and Alzheimer's Disease * , 1982, Annals of the New York Academy of Sciences.

[67]  R. Ebstein,et al.  Changes in expression of lymphocyte amyloid precursor protein mRNA isoforms in normal aging and Alzheimer's disease. , 1996, Brain research. Molecular brain research.

[68]  B. Greenberg,et al.  An interaction between basement membrane and Alzheimer amyloid precursor proteins suggests a role in the pathogenesis of Alzheimer's disease. , 1995, Laboratory investigation; a journal of technical methods and pathology.

[69]  G. Multhaup.  Identification and regulation of the high affinity binding site of the Alzheimer's disease amyloid protein precursor (APP) to glycosaminoglycans. , 1994, Biochimie.

[70]  A. Burns.  Clinical diagnosis of Alzheimer's disease , 1991 .

[71]  Schweber Ms,et al.  Alzheimer's disease and Down syndrome. , 1989, Progress in clinical and biological research.